semaglutide from india pharma companies develop versions of Wegovy to get in on weight-loss windfall WEGOVY (semaglutide) Tablets - IPN

Our Semaglutide Programs Are Medically Supervised to Ensure Effective Results.

GLP-1 Semaglutide/Tirzepatide compounded stack vial for medical weight management

The first phase 3 retatrutide trial, TRIUMPH-4, top-line data announced today Retatrutide, a triple GLP-1,GIP, glucagon agonist studied in patients with obesity and osteoarthritis 28.7% weight loss at 68 weeks Reduced key cardiometabolic risk markers non-HDL cholesterol, triglycerides, and hsCRP Highest dose lowered systolic BP by 14 mmHg Reduced WOMAC pain scores by up to an average of 4.5 points (75.8%) and significantly improved measures of physical function GI side effects most common adverse event We now await 7 additional phase 3 trials in other obesity related comorbidities

But are they designed to be used long-term? A study []

Obesity and diabetes of different types are considered global health risks with rising prevalence

As you consider semaglutide as a treatment option for weight loss, it's crucial to understand the potential long-term effects of this medication.